NEWS
Mar 27, 2026

SSRP Institute Welcomes Medivive as New Trusted Partner

PARTNER ANNOUNCEMENT

WILLOUGHBY, Ohio, [March 27, 2026] — The SSRP Institute is pleased to announce that Medivive has joined its Trusted Partner Network following nomination and internal vetting aligned with SSRP’s mission of advancing science-first, education-driven clinical collaboration.

Medivive offers an advanced approach to NAD⁺ therapy designed to support cellular energetics through sterile, clinician-prescribed formulations produced under current Good Manufacturing Practices (cGMP) and dispensed by licensed pharmacies. Delivered subcutaneously, Medivive’s NAD⁺ therapy is designed to improve bioavailability compared to oral precursors while supporting tissue energy production and redox balance under medical supervision.

Jay Palmer, CEO and Co-Founder of Medivive says, "Dr. Seeds and I have known each other for a while, and when we started talking about what Medivive was building, the fit was obvious. SSRP practitioners hold their protocols to a high standard, and the Medivive pen was built to match it. This is the first prefilled NAD+ subcutaneous injector pen manufactured to cGMP standards at a 503B outsourcing facility in the US. Drug-grade testing on every batch, delivered the right way, with zero burden on the practice. We are proud to be the preferred NAD+ provider for this community." 

"Now, we can feel more confident in measuring and following the evidence on this with a safe product,” Dr. William Seeds, Founder and Academic Chairman of the SSRP Institute said recently on Episode 50 of his podcast, Redox Revolution. “This really opens the door to some powerful things you can start doing as you work to help that patient. I mean, it's things that I have not been able to do for a very long time.”

Certificates of Analysis covering potency, sterility, and endotoxin testing are maintained for every batch and are available to prescribers upon request. Medivive’s dedicated Partner Page is now live and provides SSRP Members with information about their offerings, research background, and ways they support clinical practice.

For more information and to view the Medivive Partner Page, visit:
SSRP Medivive Partner Page


About the SSRP Institute

The SSRP Institute is an education-focused organization dedicated to advancing cellular medicine through evidence-based training, professional collaboration, and clinically relevant research. SSRP supports providers worldwide through certifications, events, and ongoing educational programming designed to improve patient outcomes and elevate the standard of care.

The SSRP Trusted Partner Network is invitation-only and based on real-world clinical relevance, thoughtful nomination, and alignment with SSRP’s educational principles. Partners are integrated through a structured process designed to foster collaboration, support clinician education, and strengthen the implementation of cellular medicine practices.

RELATED RESOURCES

Continue exploring related topics.

VIEW ALL
ARTICLE
William Seeds, MD
Aug 6, 2026
A Lipid at the Root of Mitochondrial Aging: Phosphatidylcholine, Methylation, and a Malleable Therapeutic Window
William Seeds, MD Aug 6, 2026
A Lipid at the Root of Mitochondrial Aging: Phosphatidylcholine, Methylation, and a Malleable Therapeutic Window
Mitochondrial dysfunction is one of the most firmly established hallmarks of aging, but the field has spent far more energy describing genetic causes of mitochondrial failure—mtDNA mutation, defective OXPHOS, impaired unfolded protein response—than the “natural” drivers that erode mitochondria during ordinary aging. As I discussed in my recent June Journal Club (as well as a […]
READ ARTICLE
VIDEO
Cellular Medicine Mondays
Aug 3, 2026
Ep. 099 - Dr. Seeds’ Office Hours
Preview Only
Dr. Seeds’ Office Hours – Episode 099

    1. GLOW Stack, MOTS c, and Thyroid Function (0:50)

    1. Should the GLOW Stack Be Separated? (3:31)

    1. Peptides in Transplant Medicine (8:02)

    1. Biomarker Monitoring (13:21)

    1. Peptides in Acute and Long Term Stroke Recovery (17:37)

    1. Autoimmunity and the GI Tract (23:00)

  1. Cancer Concerns Related to Hormones and Angiogenesis (26:49)

Thank you to Dr. Seeds and Dr. Newman for their expertise, and to our community for participating!

Dr. Seeds’ Office Hours – Episode 099

This special edition of Office Hours features questions submitted during the Peptide World Congress Virtual Summit on July 10 and 11. Dr. Seeds and Dr. Newman address

    1. GLOW Stack, MOTS c, and Thyroid Function (0:50)

    1. Should the GLOW Stack Be Separated? (3:31)

    1. Peptides in Transplant Medicine (8:02)

    1. Biomarker Monitoring (13:21)

    1. Peptides in Acute and Long Term Stroke Recovery (17:37)

    1. Autoimmunity and the GI Tract (23:00)

  1. Cancer Concerns Related to Hormones and Angiogenesis (26:49)

Thank you to Dr. Seeds and Dr. Newman for their expertise, and to our community for participating!

Preview Only — Become a member for full access
VIDEO
Cellular Medicine Mondays
Jul 27, 2026
Ep. 098 - Pentosan Polysulfate: Dosing, Safety, and Monitoring
Preview Only
Dissecting Protocols – Episode 098

Pentosan Polysulfate: Dosing, Safety, and Monitoring

Dr. Seeds examines the subcutaneous use of pentosan polysulfate, addressing concerns about injection site scarring and ocular safety. He discusses dosing, site rotation, cumulative exposure, retinal screening, and strategies for responsible, individualized treatment.(Question Link)

Preview Only — Become a member for full access
SSRP Institute Jul 24, 2026
PCAC Meeting Vote Summary
BREAKING NEWS JULY 24, 2026 – The Pharmacy Compounding Advisory Committee (PCAC) has completed its July session, voting on several peptide bulk drug substances for potential inclusion on the FDA’s 503A Bulks List.Recommended FOR inclusion: (Yes-No)• BPC-157 (8–6)• KPV (8–6)• TB-500 (8–6)• MOTS-c (7–5)• Epitalon (7–4)• Semax (8–5)Recommended AGAINST inclusion: (Yes-No)• DSIP (6–7) What happens […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Jul 20, 2026
Ep. 097 - Creatine: Evidence, Pathways, and Hype
Preview Only
Rabbit Holes – Episode 097

Creatine: Evidence, Pathways, and Hype

Dr. Seeds examines creatine through a cellular medicine lens, separating evidence-supported uses in ATP buffering, performance, and methylation from claims that exceed current clinical data.

Preview Only — Become a member for full access
ARTICLE
William Seeds, MD
Jul 14, 2026
The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Blood Pressure Regulation
William Seeds, MD Jul 14, 2026
The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Blood Pressure Regulation
After a recent Journal Club episode in which I featured, The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Cardiovascular Regulation, I wanted to return to the article and expand a bit on the significance of the Renin–Angiotensin–Aldosterone System (RAAS). As we know, the RAAS system has traditionally been viewed as the body’s primary mechanism for regulating blood pressure, […]
READ ARTICLE
World Congress World Congress
Peptide World Congress 2026
At Peptide World Congress 2026, join the fastest-growing community of evidence-based providers exploring the therapeutic power of clinical peptides. Learn why the body ages, when disease originates, and how top clinicians are changing their patients’ lives by treating the body...
22 Lessons
13 Hours 10 Minutes
View Course
VIDEO
Cellular Medicine Mondays
Jul 13, 2026
Ep. 096 - Stem Cells Derived from The Plucked Hair Follicle
Preview Only
Journal Club – Episode 096

Efficient Generation of Pancreatic Progenitor Cells from Induced Pluripotent Stem Cells Derived from a Non-Invasive and Accessible Tissue Source—The Plucked Hair Follicle

Dr. Seeds reviews how cryopreserved hair follicles may offer a simpler, non-invasive source for future stem cell research and pancreatic cell development. (Article Link)

Preview Only — Become a member for full access
VIDEO
Cellular Medicine Mondays
Jul 6, 2026
Ep. 095 - Dr. Seeds’ Office Hours
Preview Only
Dr. Seeds’ Office Hours – Episode 095
Preview Only — Become a member for full access
ARTICLE
Scott Sherr, MD
Jul 2, 2026
Methylene Blue: From Cellular Energy to Clinical Practice
Scott Sherr, MD Jul 2, 2026
Methylene Blue: From Cellular Energy to Clinical Practice
Scott Sherr, MD | Lucía González Forte, PhD  Submitted for publication [Article] to the SSRP Institute Abstract Methylene blue (MB) is a century-old compound whose renewed relevance in clinical medicine reflects a clearer understanding of its role in mitochondrial function, redox biology, and neuroinflammatory signaling. At therapeutic oral doses, MB acts as a catalytic electron […]
READ ARTICLE

Subscribe to the SSRP Community Digest

Get the latest research and developments in the field of Cellular Medicine straight to your inbox every month.

This field is for validation purposes and should be left unchanged.